Metabolic effects of structured triglycerides in humans

Area of Science:

• Biochemistry
• Nutritional Science
• Critical Care Medicine

Background:

• Conventional fat emulsions use long-chain fatty acids (LCFAs) for intravenous (IV) nutrition.
• LCFAs can have limitations in critically ill patients, impacting metabolism and inflammation.
• Development of alternative lipid formulations is crucial for optimizing nutritional support.

Purpose of the Study:

• To review the development and potential benefits of structured triglycerides (STs) as an IV nutrient source.
• To compare the features of STs with conventional fat emulsions for energy provision.
• To evaluate the suitability of STs for critically ill patient populations.

Main Methods:

• Literature review focusing on studies related to structured triglycerides and fat emulsions.
• Analysis of biochemical and physiological properties of STs compared to LCFAs.
• Examination of clinical data and theoretical advantages for specific patient groups.

Main Results:

• Replacing some LCFAs with medium-chain triglycerides (MCTs) or other fatty acids in triglycerides creates STs.
• STs exhibit altered physicochemical properties, potentially improving stability and metabolic handling.
• These modifications may lead to enhanced energy delivery and reduced adverse effects in certain conditions.

Conclusions:

• Structured triglycerides represent a significant advancement in IV lipid formulations.
• Their unique composition offers potential advantages over conventional fat emulsions, particularly in critical illness.
• Further research and clinical trials are warranted to fully establish the efficacy and safety of STs.